CA2643005C - Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof - Google Patents
Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof Download PDFInfo
- Publication number
- CA2643005C CA2643005C CA2643005A CA2643005A CA2643005C CA 2643005 C CA2643005 C CA 2643005C CA 2643005 A CA2643005 A CA 2643005A CA 2643005 A CA2643005 A CA 2643005A CA 2643005 C CA2643005 C CA 2643005C
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- imidazole
- butyl
- carboxylic acid
- biphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610023991.0 | 2006-02-20 | ||
| CNA2006100239910A CN101024643A (zh) | 2006-02-20 | 2006-02-20 | 咪唑－5－羧酸类衍生物、制备方法及其应用 |
| PCT/CN2006/001914 WO2007095789A1 (en) | 2006-02-20 | 2006-07-31 | Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2643005A1 CA2643005A1 (en) | 2007-08-30 |
| CA2643005C true CA2643005C (en) | 2012-05-15 |
Family
ID=38436915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2643005A Expired - Fee Related CA2643005C (en) | 2006-02-20 | 2006-07-31 | Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | USRE44873E1 (https=) |
| EP (1) | EP1988090B1 (https=) |
| JP (1) | JP5250760B2 (https=) |
| KR (1) | KR101179110B1 (https=) |
| CN (2) | CN101024643A (https=) |
| AU (1) | AU2006338796B2 (https=) |
| CA (1) | CA2643005C (https=) |
| DK (1) | DK1988090T3 (https=) |
| ES (1) | ES2424154T3 (https=) |
| PL (1) | PL1988090T3 (https=) |
| PT (1) | PT1988090E (https=) |
| WO (1) | WO2007095789A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101024643A (zh) | 2006-02-20 | 2007-08-29 | 上海艾力斯医药科技有限公司 | 咪唑－5－羧酸类衍生物、制备方法及其应用 |
| ATE525371T1 (de) * | 2006-12-06 | 2011-10-15 | Shanghai Allist Pharmaceutical Inc | Salze von imidazol-5-carbonsäure-derivaten, herstellungsverfahren und verwendung davon |
| CN101214242A (zh) | 2007-01-05 | 2008-07-09 | 上海艾力斯医药科技有限公司 | 新的药用组合物 |
| CN101317842A (zh) * | 2007-06-07 | 2008-12-10 | 上海艾力斯医药科技有限公司 | 一种咪唑-5-羧酸衍生物的治疗用途 |
| CN101407511B (zh) * | 2007-10-11 | 2013-01-09 | 上海艾力斯生物医药有限公司 | 一种结晶型的咪唑-5-羧酸衍生物 |
| AU2009246670A1 (en) * | 2008-05-15 | 2009-11-19 | Merck Sharp & Dohme Corp. | Angiotensin II receptor antagonists |
| CN101596189A (zh) * | 2008-06-05 | 2009-12-09 | 上海艾力斯生物医药有限公司 | 含有咪唑-5-羧酸类衍生物的药用组合物 |
| EP2365966A4 (en) * | 2008-12-12 | 2012-05-09 | Pharmacostech Co Ltd | PROCESS FOR REMOVING THE TRIPHENYLMETHANE GRIP |
| KR101213467B1 (ko) * | 2010-04-30 | 2012-12-20 | 진양제약주식회사 | 로자탄 대사체 이엑스피-3174 이수화물의 신규한 제조 방법 |
| CN103012377A (zh) * | 2011-09-27 | 2013-04-03 | 江苏艾力斯生物医药有限公司 | 一种咪唑-5-羧酸酯的重结晶方法 |
| CN102558064B (zh) * | 2012-01-29 | 2014-04-16 | 安润医药科技（苏州）有限公司 | 抗高血压化合物及其制备方法和应用，以及其在药学上可接受的盐 |
| CN109320501B (zh) * | 2013-11-01 | 2021-06-01 | 深圳信立泰药业股份有限公司 | 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物 |
| CN103965171A (zh) * | 2014-04-30 | 2014-08-06 | 上海艾力斯医药科技有限公司 | 一种阿利沙坦酯的制备方法 |
| CN106188012B (zh) | 2014-06-20 | 2018-11-30 | 深圳信立泰药业股份有限公司 | 一种阿利沙坦酯结晶及其制备方法及含有该结晶的药物组合物 |
| CN105218527B (zh) * | 2015-10-10 | 2018-04-24 | 江苏宝众宝达药业有限公司 | 一种exp-3174的制备方法 |
| RS66618B1 (sr) | 2016-01-20 | 2025-04-30 | Shenzhen Salubris Pharm Co Ltd | Kompozit metabolita antagonista receptora angiotenzina ii i inhibitora nep i postupak za njegovu pripremu |
| CN119371408B (zh) * | 2024-12-27 | 2025-04-22 | 安徽艾立德制药有限公司 | 一种无定形的阿利沙坦酯及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5138069A (en) | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US5196444A (en) | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| US5616599A (en) | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| AT398202B (de) * | 1991-10-04 | 1994-10-25 | Chem Pharm Forsch Gmbh | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung |
| PT573218E (pt) * | 1992-06-02 | 2001-06-29 | Sankyo Co | 4-carbonilimidazoles como antagonistas de angiotensina ii e sua utilizacao terapeutica |
| JPH083162A (ja) * | 1994-04-19 | 1996-01-09 | Tanabe Seiyaku Co Ltd | イミダゾピリジン誘導体及びその製法 |
| DK0831910T3 (da) * | 1995-06-07 | 2002-05-21 | Searle & Co | Kombinationsterapi med epoxy-steroid aldosteronantagonist og angiotensin II-receptorantagonist til behandling af kongestivt hjertesvigt |
| PL1653950T3 (pl) | 2003-07-31 | 2008-08-29 | Nicox Sa | Pochodne nitrooksylowe losartanu, walsartanu, kandesartanu, telmisartanu, eprosartanu i olmesartanu jako antagonisty receptorów angiotensyny II do leczenia chorób sercowo-naczyniowych |
| CA2536975A1 (en) | 2003-08-28 | 2005-03-17 | Nitromed, Inc. | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
| ES2334386T3 (es) | 2005-04-22 | 2010-03-09 | Daiichi Sankyo Company, Limited | Producto farmaceutico para la prevencion o el tratamiento de una enfermedad metabolica osea. |
| CN101024643A (zh) | 2006-02-20 | 2007-08-29 | 上海艾力斯医药科技有限公司 | 咪唑－5－羧酸类衍生物、制备方法及其应用 |
| ATE525371T1 (de) | 2006-12-06 | 2011-10-15 | Shanghai Allist Pharmaceutical Inc | Salze von imidazol-5-carbonsäure-derivaten, herstellungsverfahren und verwendung davon |
| CN101214242A (zh) | 2007-01-05 | 2008-07-09 | 上海艾力斯医药科技有限公司 | 新的药用组合物 |
| CN101317842A (zh) | 2007-06-07 | 2008-12-10 | 上海艾力斯医药科技有限公司 | 一种咪唑-5-羧酸衍生物的治疗用途 |
| CN101407511B (zh) | 2007-10-11 | 2013-01-09 | 上海艾力斯生物医药有限公司 | 一种结晶型的咪唑-5-羧酸衍生物 |
-
2006
- 2006-02-20 CN CNA2006100239910A patent/CN101024643A/zh active Pending
- 2006-07-31 KR KR1020087022811A patent/KR101179110B1/ko not_active Expired - Fee Related
- 2006-07-31 US US13/727,587 patent/USRE44873E1/en active Active
- 2006-07-31 CN CNB2006800003978A patent/CN100506818C/zh active Active
- 2006-07-31 ES ES06775249T patent/ES2424154T3/es active Active
- 2006-07-31 US US11/576,094 patent/US7858651B2/en active Active
- 2006-07-31 WO PCT/CN2006/001914 patent/WO2007095789A1/zh not_active Ceased
- 2006-07-31 AU AU2006338796A patent/AU2006338796B2/en not_active Ceased
- 2006-07-31 PT PT67752493T patent/PT1988090E/pt unknown
- 2006-07-31 JP JP2008555597A patent/JP5250760B2/ja not_active Expired - Fee Related
- 2006-07-31 CA CA2643005A patent/CA2643005C/en not_active Expired - Fee Related
- 2006-07-31 DK DK06775249.3T patent/DK1988090T3/da active
- 2006-07-31 EP EP06775249.3A patent/EP1988090B1/en not_active Not-in-force
- 2006-07-31 PL PL06775249T patent/PL1988090T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009527509A (ja) | 2009-07-30 |
| CN100506818C (zh) | 2009-07-01 |
| EP1988090A4 (en) | 2010-06-30 |
| USRE44873E1 (en) | 2014-04-29 |
| EP1988090B1 (en) | 2013-05-01 |
| CN101031562A (zh) | 2007-09-05 |
| AU2006338796A1 (en) | 2007-08-30 |
| KR20080096707A (ko) | 2008-10-31 |
| CA2643005A1 (en) | 2007-08-30 |
| PL1988090T3 (pl) | 2013-10-31 |
| ES2424154T3 (es) | 2013-09-27 |
| KR101179110B1 (ko) | 2012-09-07 |
| US20090036505A1 (en) | 2009-02-05 |
| US7858651B2 (en) | 2010-12-28 |
| PT1988090E (pt) | 2013-08-05 |
| WO2007095789A1 (en) | 2007-08-30 |
| DK1988090T3 (da) | 2013-08-05 |
| EP1988090A1 (en) | 2008-11-05 |
| AU2006338796B2 (en) | 2011-05-12 |
| CN101024643A (zh) | 2007-08-29 |
| JP5250760B2 (ja) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2643005C (en) | Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof | |
| US7943648B2 (en) | Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same | |
| EP1742938A1 (en) | Preparation of candesartan cilexetil in high purity | |
| JP2009527509A5 (https=) | ||
| CN101367795B (zh) | 一种咪唑-5-羧酸衍生物及其制备方法 | |
| US20040034077A1 (en) | Processes for preparing losartan and losartan an potassium | |
| CA2542499A1 (en) | Preparation of candesartan cilexetil | |
| CN101195615B (zh) | 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物 | |
| EP2188279A2 (en) | 1,3 and 1,3,5 substituted imidazoles as antihypertensiva | |
| JP3032844B2 (ja) | ピリミジンジオン誘導体 | |
| KR20100110438A (ko) | 올메살탄의 신규한 에스테르 화합물, 이의 중간체, 이의 제조방법 및 이를 포함하는 조성물 | |
| WO2000031071A1 (en) | 2-alkyl-5-halo-3-[2'-(tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-imidazole-4-carboxaldehyde acetal derivatives, their preparation and use | |
| WO2006076710A2 (en) | Preparation of crude candesartan cilexetil | |
| KR980009263A (ko) | 벤조푸란계 치환기를 갖는 피리딜 이미다졸 유도체, 그의 제조방법 및 그를 함유하는 혈압 하제 | |
| EP1634880A2 (en) | Processes for preparing losartan and losartan potassium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20210803 |